ShenZhen New Industries Biomedical Engineering (300832.SZ): Glutamate Dehydrogenase Assay Kit (-Ketoglutamic Acid Substrate Method) Obtains Medical Device Registration Certificate.

ShenZhen New Industries Biomedical Engineering (300832.SZ) announced that the company has received a "medical device registration certificate" issued by the Guangdong Provincial Drug Administration. The product is: "Glutamic dehydrogenase assay kit (-ketoglutaric acid substrate method)". Glutamic dehydrogenase (GLDH) is an active enzyme widely distributed in liver, heart muscle, and kidney tissue cells. It mainly exists in the mitochondrial matrix and inner membrane of these visceral tissues, as a zinc-containing mitochondrial enzyme with the highest activity in liver tissue. GLDH plays an important role in amino acid breakdown and synthesis metabolism in the liver, catalyzing the dehydrogenation and deamination of glutamic acid to ultimately produce -ketoglutaric acid. This reaction is a key step in the dehydrogenation and deamination of most amino acids in the body, and is a central link connecting amino acid metabolism and the tricarboxylic acid cycle.